Significance of baseline neutrophil-to-lymphocyte ratio for progression-free survival of patients with HER2-positive breast cancer treated with trastuzumab emtansine

The efficacy of trastuzumab emtansine (T-DM1) is prolonged for some patients; however, the predictive factors remain unknown. We focused on a peripheral blood biomarker, the neutrophil-to-lymphocyte ratio (NLR), regarding T-DM1 treatment efficacy. Fifty-three advanced or metastatic breast cancers tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Imamura, Michiko, Morimoto, Takashi, Egawa, Chiyomi, Fukui, Reiko, Bun, Ayako, Ozawa, Hiromi, Miyagawa, Yoshimasa, Fujimoto, Yukie, Higuchi, Tomoko, Miyoshi, Yasuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372578/
https://www.ncbi.nlm.nih.gov/pubmed/30755651
http://dx.doi.org/10.1038/s41598-018-37633-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372578/
https://www.ncbi.nlm.nih.gov/pubmed/30755651
http://dx.doi.org/10.1038/s41598-018-37633-0

Ejemplares similares